Screener
Cogent Biosciences, Inc. COGT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Cogent Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
FAQ
- What is Cogent Biosciences, Inc.'s current ratio?
- Cogent Biosciences, Inc. (COGT) reported current ratio of 15.1× in Q1 2026.
- How has Cogent Biosciences, Inc.'s current ratio changed year-over-year?
- Cogent Biosciences, Inc.'s current ratio increased by 195.3% year-over-year, from 5.1× to 15.1×.
- What is the long-term trend for Cogent Biosciences, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s current ratio has grown at a -5.3% compound annual growth rate (CAGR), from 18.7× to 14.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Cogent Biosciences, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude